Position in CYTK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$247,731
+$47,644 QoQ
Shares Held
2,908
-7.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#353
of 477 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ascent Group, LLC holds $3,956,864 across 9 Biotechnology names. CYTK ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,701 | $1,838,394 | |
| 2 | EXEL |
Exelixis, Inc.
|
7,738 | $421,022 | |
| 3 | BCAX |
Bicara Therapeutics Inc.
|
14,176 | $420,883 | |
| 4 | ANAB |
Anaptysbio, Inc
|
5,598 | $377,865 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
2,908 | $247,731 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
896 | $215,907 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
329 | $205,143 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
10,008 | $169,834 |
All Filings in CYTK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $247,731 | 2,908 | Shares | Other | 2026-08-03 | |
| 2025-12-31 | $200,087 | 3,149 | Shares | Other | 2026-01-20 | |
| No filing history on record for this holder in this stock. | ||||||